ICAD
ICAD Inc
Price:  
3.32 
USD
Volume:  
487,990.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-163.3%
Upside

As of 2025-02-17, the EV/EBITDA ratio of ICAD Inc (ICAD) is -13.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 69.32 mil USD. ICAD's TTM EBITDA according to its financial statements is -5.30 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.4x - 17.7x 11.0x
Forward P/E multiples 10.7x - 18.9x 17.1x
Fair Price (1.44) - (2.83) (2.10)
Upside -143.3% - -185.2% -163.3%
3.32 USD
Stock Price
(2.10) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-14 -13.08
2025-02-13 -14.53
2025-02-12 -14.13
2025-02-11 -13.83
2025-02-10 -14.48
2025-02-07 -12.83
2025-02-06 -13.83
2025-02-05 -14.93
2025-02-04 -12.98
2025-02-03 -11.78
2025-01-31 -12.48
2025-01-30 -12.18
2025-01-29 -14.98
2025-01-28 -13.48
2025-01-27 -10.72
2025-01-24 -8.57
2025-01-23 -8.27
2025-01-22 -8.52
2025-01-21 -7.12
2025-01-17 -6.29
2025-01-16 -5.97
2025-01-15 -5.87
2025-01-14 -6.22
2025-01-13 -6.02
2025-01-10 -5.97
2025-01-08 -6.27
2025-01-07 -6.77
2025-01-06 -6.57
2025-01-03 -6.77
2025-01-02 -6.42
2024-12-31 -5.62
2024-12-30 -6.04
2024-12-27 -6.22
2024-12-26 -5.77
2024-12-24 -5.37
2024-12-23 -4.89
2024-12-20 -5.62
2024-12-19 -5.32
2024-12-18 -4.87
2024-12-17 -5.42
2024-12-16 -5.52
2024-12-13 -6.22
2024-12-12 -6.32
2024-12-11 -6.32
2024-12-10 -5.92
2024-12-09 -5.87
2024-12-06 -5.17
2024-12-05 -4.87
2024-12-04 -4.97
2024-12-03 -4.97